TL;DR
Spatial structure in bacterial populations can surprisingly facilitate their survival against antibiotic treatment. By promoting the local fixation of rare resistant mutants in smaller subpopulations, structured environments act as "refugia," allowing the population to persist and eventually overcome the drug, even when resistance comes with a fitness cost.
What Problem Does This Paper Address?
Antibiotic resistance is a critical global health challenge. Bacteria evolve resistance through mutations, and understanding the factors that accelerate or hinder this process is crucial. While it's known that antibiotic resistance can emerge and spread rapidly, the role of the physical environment in which bacteria live – their spatial structure – is less understood. Most natural bacterial populations aren't uniformly distributed; they exist in complex, structured environments like gut microbiota or biofilms. This paper investigates how this spatial structure influences a bacterial population's ability to survive antibiotic treatment, particularly when resistance arises from rare mutations.
Methods
The researchers employed a combination of analytical modeling and stochastic simulations. They developed a minimal model of spatially structured bacterial populations, conceptualized as a "clique" or "island model," where multiple identical subpopulations (demes) are connected by migration. They then simulated the evolution of these populations under antibiotic treatment, focusing on the "rare mutation regime" where resistant mutants are infrequent. Key analytical tools included the Moran model for population dynamics and probability theory to derive fixation probabilities and timescales. Simulations were performed using the Gillespie algorithm, a standard method for modeling stochastic processes.
Datasets
Not discussed in the paper. The study relies on simulated data generated from their mathematical models.
Key Insights and Ideas
- Spatial Structure as a Shield: Contrary to intuition, spatial structure doesn't just hinder bacteria; it can actively help them survive antibiotics.
- Local Fixation is Key: The critical mechanism is the increased probability of neutral or slightly deleterious resistance mutations fixing within individual, smaller subpopulations (demes).
- Demes as Refugia: These demes where resistance has fixed act as "refugia" for resistant bacteria, allowing them to survive the antibiotic onslaught that eradicates sensitive bacteria.
- Rare Mutation Regime Matters: The effect is most pronounced when resistance arises from rare mutations, as spatial structure can give these rare events a better chance to establish locally.
- Migration is a Double-Edged Sword: Lower migration rates between demes enhance the effect by preventing sensitive bacteria from re-invading resistant refugia, but some migration is needed for resistant mutants to spread after the initial rescue.
- Cost of Resistance is Mitigated: Even if resistance mutations carry a fitness cost in the absence of antibiotics, spatial structure can still facilitate survival by providing refugia.
Key Results
- Increased Survival Probability: Spatial structure significantly increases the probability of a bacterial population surviving antibiotic treatment, especially when the drug is added after some time has passed, allowing for the potential emergence of resistant mutants.
- Effect of Subdivision: Increasing the number of demes (subdivision) and decreasing migration rates between them leads to higher survival probabilities.
- Timescale Advantage: Resistant mutants are predicted to fix locally in structured populations faster than they would in a well-mixed population of the same total size, particularly for neutral or slightly deleterious mutations.
- Robustness: The findings hold for more complex spatial structures (like lattices and stars) and even when resistant mutants are present in the initial inoculum.
Limitations and Future Work
- Minimal Model: The study uses a simplified model with identical demes and homogeneous environments. Real-world environments are often heterogeneous, which could further influence resistance evolution.
- Biostatic Drug: The primary analysis focuses on a "biostatic" drug that stops division but doesn't kill sensitive bacteria. While the authors suggest their findings generalize to biocidal drugs, further investigation is warranted.
- Long Timescales: The effect of spatial structure is most pronounced for neutral or slightly deleterious mutations, which can involve very long timescales, making experimental validation challenging.
- Future Directions: The authors suggest exploring more complex spatial structures, environmental heterogeneities, and the role of public-good resistance mechanisms (like beta-lactamase production). They also highlight the need for experimental validation, particularly in setups that can accommodate the long timescales involved.
Summary updated